Top

World Journal of Surgery

Published in:

01-01-2012

Influence of Preoperative Chemotherapy on the Intraoperative and Postoperative Course of Liver Resection for Colorectal Cancer Metastases

Authors: Lidewij Spelt, Lina Hermansson, Bobby Tingstedt, Roland Andersson

Published in: World Journal of Surgery | Issue 1/2012

Abstract

Background

Liver resection is a possibly curative treatment for colorectal cancer (CRC) liver metastases. Preoperative chemotherapy may make initially irresectable tumors resectable. The aim of this study was to compare perioperative course and short-term mortality after liver resection for CRC metastases between patients who were and were not treated with preoperative chemotherapy.

Methods

Patients who had undergone liver resection for CRC metastases were included. A total of 97 patients treated with preoperative chemotherapy (group A) were compared with 136 who were not (group B). Intraoperative bleeding, operating time, complications, duration of stay, and mortality were compared using Pearson’s χ² test, Fisher’s exact test, and the Mann–Whitney U-test.

Results

Mean intraoperative bleeding, duration of stay, and operating time were not significantly different. Complications occurred in 62.9% and 63.2% in groups A and B, respectively. The 30- and 90-day mortality rates were zero in group A, comparable to 1.5% in group B.

Conclusions

There were no significant differences in the perioperative course or postoperative mortality when comparing CRC patients with or without chemotherapy prior to liver resection. Consequently, this study suggests that preoperative chemotherapy before liver resection for CRC metastases does not negatively influence perioperative outcome and can therefore be applied if “downstaging” is indicated.

Statistics Sweden. http://www.scb.se, accessed September 15, 2010

Jemal A, Siegel R, Ward E et al (2009) Cancer statistics. CA Cancer J Clin 59:225–249PubMedCrossRef

American Cancer Society (2009). Cancer facts and figures. American Cancer Society, Atlanta, GA. Available at: http://www.cancer.org/. Accessed September 15, 2010

Leporrier J, Maurel J, Chiche L et al (2006) A population-based study of the incidence, management and prognosis of hepatic metastases from colorectal cancer. Br J Surg 93:465–474PubMedCrossRef

Bengmark S, Hafström L (1969) The natural history of primary and secondary malignant tumors of the liver. I. The prognosis for patients with hepatic metastases from colonic and rectal carcinoma by laparotomy. Cancer 23:198–202PubMedCrossRef

Bengtsson G, Carlsson G, Hafström L et al (1981) Natural history of patients with untreated liver metastases from colorectal cancer. Am J Surg 141:586–589PubMedCrossRef

Tan MC, Castaldo ET, Gao F et al (2008) A prognostic system applicable to patients with resectable liver metastasis from colorectal carcinoma staged by positron emission tomography with [¹⁸F]fluoro-2-deoxy-d-glucose: role of primary tumor variables. J Am Coll Surg 206:857–868PubMedCrossRef

Rees M, Tekkis PP, Welsh FK et al (2008) Evaluation of long-term survival after hepatic resection for metastatic colorectal cancer: a multifactorial model of 929 patients. Ann Surg 247:125–135PubMedCrossRef

Abdalla EK, Vauthey JN, Ellis LM et al (2004) Recurrence and outcomes following hepatic resection, radiofrequency ablation, and combined resection/ablation for colorectal liver metastases. Ann Surg 239:818–825PubMedCrossRef

10.

Fernandez FG, Drebin JA, Linehan DC et al (2004) Five-year survival after resection of hepatic metastases from colorectal cancer in patients screened by positron emission tomography with F-18 fluorodeoxyglucose (FDG-PET). Ann Surg 240:438–447PubMedCrossRef

11.

Choti MA, Sitzmann JV, Tiburi MF et al (2002) Trends in long-term survival following liver resection for hepatic colorectal metastases. Ann Surg 235:759–766PubMedCrossRef

12.

Fong Y, Cohen AM, Fortner JG et al (1997) Liver resection for colorectal metastases. J Clin Oncol 15:938–946PubMed

13.

Doci R, Gennari L, Bignami P et al (1991) One hundred patients with hepatic metastases from colorectal cancer treated by resection: analysis of prognostic determinants. Br J Surg 78:797–801PubMedCrossRef

14.

Rees M, Plant G, Bygrave S (1997) Late results justify resection for multiple hepatic metastases from colorectal cancer. Br J Surg 84:1136–1140PubMedCrossRef

15.

Adam R, Avisar E, Ariche A et al (2001) Five-year survival following hepatic resection after neoadjuvant therapy for nonresectable colorectal. Ann Surg Oncol 8:347–353PubMedCrossRef

16.

Ito K, Govindarajan A, Ito H et al (2010) Surgical treatment of hepatic colorectal metastasis: evolving role in the setting of improving systemic therapies and ablative treatments in the 21st century. Cancer J 16:103–110PubMedCrossRef

17.

Pozzo C, Basso M, Cassano A et al (2004) Neoadjuvant treatment of unresectable liver disease with irinotecan and 5-fluorouracil plus folinic acid in colorectal cancer patients. Ann Oncol 15:933–939PubMedCrossRef

18.

Kooby DA, Fong Y, Suriawinata A et al (2003) Impact of steatosis on perioperative outcome following hepatic resection. J Gastrointest Surg 7:1034–1044PubMedCrossRef

19.

Parikh AA, Gentner B, Wu TT et al (2003) Perioperative complications in patients undergoing major liver resection with or without neoadjuvant chemotherapy. J Gastrointest Surg 7:1082–1088PubMedCrossRef

20.

Fernandez FG, Ritter J, Goodwin JW et al (2005) Effect of steatohepatitis associated with irinotecan or oxaliplatin pretreatment on resectability of hepatic colorectal metastases. J Am Coll Surg 200:845–853PubMedCrossRef

21.

Vauthey JN, Pawlik TM, Ribero D et al (2006) Chemotherapy regimen predicts steatohepatitis and an increase in 90-day mortality after surgery for hepatic colorectal metastases. J Clin Oncol 24:2065–2072PubMedCrossRef

22.

Rubbia-Brandt L, Mentha G, Terris B (2006) Sinusoidal obstruction syndrome is a major feature of hepatic lesions associated with oxaliplatin neoadjuvant chemotherapy for liver colorectal metastases. J Am Coll Surg 202:199–200PubMedCrossRef

23.

Dindo D, Demartines N, Clavien PA (2004) Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg 240:205–213PubMedCrossRef

24.

Zeiss J, Merrick HW, Savolaine ER et al (1990) Fatty liver change as a result of hepatic artery infusion chemotherapy. Am J Clin Oncol 13:156–160PubMedCrossRef

25.

Sorensen P, Edal AL, Madsen EL et al (1995) Reversible hepatic steatosis in patients treated with interferon alfa-2a and 5-fluorouracil. Cancer 15 75:2592–2596CrossRef

26.

Didolkar MS, Fitzpatrick JL, Elias EG et al (1989) Risk factors before hepatectomy, hepatic function after hepatectomy and computed tomographic changes as indicators of mortality from hepatic failure. Surg Gynecol Obstet 169:17–26PubMed

27.

Pocard M, Vincent-Salomon A, Girodet J et al (2001) Effects of preoperative chemotherapy on liver function tests after hepatectomy. Hepatogastroenterology 48:1406–1408PubMed

28.

Gomez D, Malik HZ, Bonney GK et al (2007) Steatosis predicts postoperative morbidity following hepatic resection for colorectal metastasis. Br J Surg 94:1395–1402PubMedCrossRef

29.

Belghiti J, Hiramatsu K, Benoist S et al (2000) Seven hundred forty-seven hepatectomies in the 1990 s: an update to evaluate the actual risk of liver resection. J Am Coll Surg 191:38–46PubMedCrossRef

30.

Scoggins CR, Campbell ML, Landry CS et al (2009) Preoperative chemotherapy does not increase morbidity or mortality of hepatic resection for colorectal cancer metastases. Ann Surg Oncol 16:35–41PubMedCrossRef

31.

Welsh FK, Tilney HS, Tekkis PP et al (2007) Safe liver resection following chemotherapy for colorectal metastases is a matter of timing. Br J Cancer 96:1037–1042PubMedCrossRef

32.

Mehta NN, Ravikumar R, Coldham CA et al (2008) Effect of preoperative chemotherapy on liver resection for colorectal liver metastases. Eur J Surg Oncol 34:782–786PubMedCrossRef

33.

Nordlinger B, Sorbye H, Glimelius B et al (2008) Perioperative chemotherapy with FOLFOX4 and surgery versus surgery alone for resectable liver metastases from colorectal cancer (EORTC Intergroup trial 40983): a randomised controlled trial. Lancet 371:1007–1016PubMedCrossRef

34.

Bismuth H, Adam R, Levi F et al (1996) Resection of nonresectable liver metastases from colorectal cancer after neoadjuvant chemotherapy. Ann Surg 224:509–520PubMedCrossRef

Title: Influence of Preoperative Chemotherapy on the Intraoperative and Postoperative Course of Liver Resection for Colorectal Cancer Metastases
Authors: Lidewij Spelt
Lina Hermansson
Bobby Tingstedt
Roland Andersson
Publication date: 01-01-2012
Publisher: Springer-Verlag
Published in: World Journal of Surgery / Issue 1/2012
Print ISSN: 0364-2313
Electronic ISSN: 1432-2323
DOI: https://doi.org/10.1007/s00268-011-1342-x

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Influence of Preoperative Chemotherapy on the Intraoperative and Postoperative Course of Liver Resection for Colorectal Cancer Metastases

Abstract

Background

Methods

Results

Conclusions

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Abstract

Background

Methods

Results

Conclusions

Please log in to get access to this content

Other articles of this Issue 1/2012

Incidence of Malignancy in Thyroid Nodules Determined to be Follicular Lesions of Undetermined Significance on Fine-Needle Aspiration

Ghrelin Agonist TZP-101/Ulimorelin Accelerates Gastrointestinal Recovery Independently of Opioid Use and Surgery Type: Covariate Analysis of Phase 2 Data

Correlation of Vascular Endothelial Growth Factor Expression With Tumor Recurrence and Poor Prognosis in Patients With pN0 Gastric Cancer

Bridging the Gap with an Ileocolonic Graft after Extensive Colorectal Resections

Risk Factors for Prolonged Postoperative Ileus After Colorectal Cancer Surgery

Survival Analysis of Re-resection Versus Radiofrequency Ablation for Intrahepatic Recurrence After Hepatectomy for Hepatocellular Carcinoma